UPDATED Aug 12, 2022
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| XBRANEXbrane Biopharma | kr87.10 | -1.9% | -42.0% | kr2.2b | kr235.00 | PS123.5x | E181.6% | n/a | ||
| 6446PharmaEssentia | NT$537.00 | -13.2% | 466.5% | NT$152.6b | NT$395.33 | PS188.3x | E168.5% | n/a | ||
| BHCBausch Health Companies | US$6.01 | 7.5% | -78.2% | US$2.2b | US$13.25 | PE50.6x | E164.1% | 0% | ||
| LOWLLowell Farms | CA$0.29 | 1.7% | -80.7% | CA$29.7m | n/a | PB0.4x | E158.2% | n/a | ||
| VRNOVerano Holdings | CA$6.97 | 2.5% | -56.6% | CA$2.3b | CA$27.09 | PS2.2x | E155.9% | n/a | ||
| ORGSOrgenesis | US$1.80 | 1.1% | -65.1% | US$44.7m | US$9.00 | PS1.3x | E148.5% | n/a | ||
| SOLARASolara Active Pharma Sciences | ₹384.10 | 1.8% | -77.7% | ₹13.8b | ₹500.33 | PS1.2x | E146.3% | 0% | ||
| BIOBio-Rad Laboratories | US$548.74 | 1.7% | -29.5% | US$16.1b | US$641.33 | PS5.7x | E142.1% | n/a | ||
| 4147TaiMed Biologics | NT$54.30 | 1.3% | -17.2% | NT$13.7b | NT$101.33 | PS37.8x | E139.7% | n/a | ||
| AYURAyurcann Holdings | CA$0.095 | -5.0% | -60.4% | CA$11.6m | n/a | PE29x | E138.3% | n/a | ||
| NOTVInotiv | US$26.17 | 38.8% | -10.2% | US$667.7m | US$62.00 | PS1.6x | E137.6% | n/a | ||
| MEDCLMedinCell | €5.30 | 2.9% | -41.6% | €133.1m | €14.50 | PS16x | E136.4% | n/a | ||
| ALPATPlant Advanced Technologies | €16.95 | 1.2% | -11.5% | €18.4m | €27.70 | PS4.2x | E136.0% | n/a | ||
| 4541Nichi-Iko Pharmaceutical | JPÂ¥343.00 | -0.3% | -59.1% | JPÂ¥24.2b | JPÂ¥190.00 | PB1.8x | E133.2% | 0% | ||
| TILTTILT Holdings | CA$0.23 | 0% | -62.7% | CA$88.3m | n/a | PB0.3x | E132.4% | n/a | ||
| IMCCIM Cannabis | CA$0.83 | 15.3% | -86.3% | CA$57.8m | CA$6.00 | PB0.3x | E131.1% | n/a | ||
| PHIOPhio Pharmaceuticals | US$0.74 | 2.8% | -57.0% | US$10.1m | US$6.00 | PB0.6x | E130.7% | n/a | ||
| GUDKnight Therapeutics | CA$6.06 | 7.1% | 8.2% | CA$694.6m | CA$7.05 | PS2.6x | E130.7% | n/a | ||
| STARStrides Pharma Science | ₹349.25 | 1.1% | -47.3% | ₹31.4b | ₹449.00 | PB1.3x | E128.4% | 0% | ||
| NYKDNykode Therapeutics | kr38.52 | 8.9% | -47.8% | kr11.2b | kr102.00 | PS32.4x | E126.4% | n/a | ||
| ISABInhalation Sciences Sweden | kr6.34 | -4.2% | -39.6% | kr72.1m | kr23.00 | PS8.3x | E125.6% | n/a | ||
| CANBCan B | US$3.50 | -20.5% | -74.6% | US$12.1m | US$10.00 | PS2x | E123.9% | n/a | ||
| XRTXXORTX Therapeutics | CA$1.92 | 2.7% | -61.5% | CA$24.9m | n/a | PB2x | E122.0% | n/a | ||
| BONEXBonesupport Holding | kr76.20 | 10.9% | 1.7% | kr4.9b | kr91.00 | PS19.1x | E120.2% | n/a |